Cannabist CO Holdings INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
The Cannabist Company Holdings Inc. has entered into definitive agreements to sell its Maryland cultivation, manufacturing, and retail operations, along with associated real estate, for up to $13.75 million in cash.
The Cannabist Company Holdings Inc. announced the resignation of its President, Jesse Channon, effective April 1, 2026, who will transition to a non-employee consultant role.
The Cannabist Company Holdings Inc. has commenced CCAA proceedings and entered into definitive agreements to sell its Ohio and Delaware cannabis operations for a combined $63.5 million, while also planning to wind down operations in New York and Pennsylvania.
The Cannabist Company Holdings Inc. announced a further extension of its forbearance agreement with noteholders until March 6, 2026, regarding its senior secured notes.
The Cannabist Company Holdings Inc. secured a further extension of its forbearance agreement with senior secured noteholders until February 27, 2026, signaling ongoing debt negotiations.
The Cannabist Company Holdings Inc. entered a forbearance agreement with noteholders after missing December 2025 interest payments to preserve liquidity.
The Cannabist Company Holdings Inc. issued a qualified partial redemption notice for its senior secured notes, contingent on an equity purchase agreement.
The Cannabist Company Holdings Inc. has elected not to make an interest payment on its senior secured notes, initiating a 30-day grace period as it reviews strategic alternatives.
The Cannabist Company Holdings Inc. has agreed to sell its Virginia cannabis assets to Parma Holdco LLC for $130 million, terminating a prior agreement with Curaleaf.
The Cannabist Company Holdings Inc. has approved a new $2.74 million key employee retention bonus program, replacing a prior transaction-based plan.
The Cannabist Company has agreed to sell its Virginia cannabis cultivation, production, and retail assets to a Curaleaf subsidiary for $110 million, as part of a strategic review.
The Cannabist Company Holdings Inc. has agreed to sell its Green Leaf Medical of Virginia subsidiary to Curaleaf, Inc. for $110 million in cash and a promissory note.
The Cannabist Company Holdings Inc. announced its CFO, Derek Watson, transitioned from an employee to a non-employee consultant, effective November 15, 2025.
The Cannabist Company reported a sequential improvement in net loss and cash position for Q3 2025, driven by strategic divestitures and operational optimization, despite declining revenue and Adjusted EBITDA.
Co-founder Michael Abbott resigns from Cannabist Company Board, effective October 3, 2025.
The Cannabist Company Holdings Inc. announced the results of its annual general meeting, where shareholders elected seven directors and re-appointed PKF OConnor Davies, LLP as auditor.
The Cannabist Company reported a 1% sequential revenue decrease to $86.4 million in Q2 2025, alongside a 30-basis point improvement in Adjusted EBITDA margin to 9.8%.
The Cannabist Company Holdings Inc. has established a new Transaction Bonus Plan for key employees, including named executive officers, linked to the value of future strategic divestitures, and updated its President's employment agreement to enhance severance provisions.
The Cannabist Company Holdings Inc. has appointed Tom Lynch and Peter Lee to its Board of Directors, fulfilling terms of a recent Amended and Restated Indenture with Supporting Senior Noteholders.
The Cannabist Company Holdings Inc. has successfully completed a court-approved plan of arrangement, significantly restructuring its debt by exchanging existing notes for new senior and convertible notes, and issuing new common shares and anti-dilutive warrants.
8-K: Cannabist Co Holdings Inc. Receives Final Court Order for Arrangement, Targeting May 29 Closing
The Cannabist Company Holdings Inc. has secured the final court order for its arrangement plan and aims to close the deal around May 29, 2025, pending regulatory approvals.
The Cannabist Company announced its first quarter 2025 financial results, showing a decrease in revenue but improvements in adjusted gross margin and adjusted EBITDA margin.
Cannabist Co. Holdings reports that its plan of arrangement, involving debt restructuring and issuance of new common shares, has been approved by senior noteholders, but remains subject to court approval.
The Cannabist Company announced its Q4 and full year 2024 financial results, highlighting revenue declines due to asset sales but also cost savings from corporate restructuring.
8-K: Cannabist Co Holdings Reaches Agreement to Extend Senior Secured Notes Maturity to December 2028
Cannabist Co Holdings Inc. has entered into a support agreement with noteholders to extend the maturity date of its senior secured notes to December 2028, with options for further extension.
The Cannabist Company Holdings Inc. has dismissed Davidson & Company LLP as its independent auditor and appointed PKF O'Connor Davies, LLP, effective October 9, 2024.
Cannabist Co. has amended its exchange agreement, extending the deadline for noteholders to exchange debt for common shares to January 31, 2025.
The Cannabist Company Holdings Inc. is divesting its Florida operations, selling its cultivation facility and related assets for a total of $16.4 million.
The Cannabist Company has finalized the sale of its Virginia and Arizona operations to Verano Holdings for a total consideration including cash, stock, and a promissory note.
The Cannabist Company Holdings Inc. has agreed to sell its operations in Eastern Virginia and Arizona to Verano Holdings Corp. for a total consideration of $105 million.